These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7902767)

  • 1. Schizophrenia--falling incidence and better outcome?
    Harrison G; Mason P
    Br J Psychiatry; 1993 Oct; 163():535-41. PubMed ID: 7902767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodological constraints in evaluating anti-deficit effects].
    Boyer P; Lecrubier Y; Rein W
    Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcome in chronic schizophrenia.
    Schwartz F; Terkelsen KG; Smith TE
    Arch Gen Psychiatry; 1992 Jun; 49(6):502-3. PubMed ID: 1350900
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Deficit schizophrenias].
    Puech AJ
    Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
    [No Abstract]   [Full Text] [Related]  

  • 9. Untreated psychosis and long-term outcome in schizophrenia.
    Waddington JL; Scully PJ
    Schizophr Bull; 1998; 24(1):34-5. PubMed ID: 9502545
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacoepidemiology of treatment-refractory schizophrenia.
    Collins EJ; Hogan TP; Awad AG
    Can J Psychiatry; 1992 Apr; 37(3):192-5. PubMed ID: 1350502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 17. The Relevance of Negative Symptoms in Schizophrenia and How to Treat Them with Psychopharmaceuticals?
    Möller HJ
    Psychiatr Danub; 2016 Dec; 28(4):435-440. PubMed ID: 27855437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance therapy and the natural course of schizophrenia.
    Davis JM
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding schizophrenia: the impact of novel antipsychotics.
    Remington G
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S29-32. PubMed ID: 8564914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
    Naber D; Lambert M; Karow A
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.